KIDNEYCARE
Live / Registered — Registered (as of 08 Dec 2020)
What this means for you
Registered since 08 Dec 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88611726
- Registration number
- 6217846
- Mark type
- Design + words
- Filed
- 10 Sept 2019
- Published for opposition
- 21 Jan 2020
- Registered
- 08 Dec 2020
- Attorney of record
- Theresa Conduah
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic testing kits comprised of medical diagnostic reagents and assays for organ transplant surveillance, including damage, rejection, or tolerance
- Class 044 — Medical, beauty and agricultural services: Medical diagnostic services, namely, gene expression testing to determine immune response; medical diagnostic services, namely, cell-free DNA testing for medical purposes; medical diagnostic testing, namely, donor-specific cell-free DNA testing to determine immune response and organ transplant rejection or tolerance; medical diagnostic testing services, namely, blood-based testing to determine immune response and organ transplant rejection or tolerance
Owner
- CareDx, Inc., Brisbane, CA, US
- CareDx, Inc., Brisbane, CA, US
- CareDx, Inc., Brisbane, CA, US
Prosecution history
- 08 Dec 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Mar 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Mar 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Mar 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Dec 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 18 Dec 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Dec 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Dec 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Dec 2020 — REGISTERED-PRINCIPAL REGISTER
- 03 Nov 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Nov 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Oct 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Sept 2020 — USE AMENDMENT FILED
- 02 Oct 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Sept 2020 — TEAS STATEMENT OF USE RECEIVED